We are live on
!
Find out more
Adage Capital Partners Portfolio holdings
AUM
$64.8B
1-Year Est. Return
42.7%
This Fund
S&P 500
This Quarter
Est. Return
+27.07%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$39.1B
AUM Growth
+$5.57B
(+17%)
Cap. Flow
-$1.33B
Cap. Flow
% of AUM
-3.4%
Top 10 Holdings %
Top 10 Hldgs %
25.2%
Holding
834
New
111
Increased
262
Reduced
309
Closed
110
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Royalty Pharma
RPRX
|
+$2.28B |
| 2 |
Otis Worldwide
OTIS
|
+$193M |
| 3 |
Burlington
BURL
|
+$191M |
| 4 |
AbbVie
ABBV
|
+$178M |
| 5 |
Wayfair
W
|
+$144M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$1.66B |
| 2 |
Lockheed Martin
LMT
|
+$339M |
| 3 |
Johnson & Johnson
JNJ
|
+$262M |
| 4 |
Pfizer
PFE
|
+$167M |
| 5 |
Target
TGT
|
+$141M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 21.52% |
| 2 | Healthcare | 19.78% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Financials | 11.33% |
| 5 | Industrials | 8.42% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
151
Pfizer
PFE
$143B
| $60.9M | 0.16% |
1,963,814
-4,930,275
| -72% | -$167M |
|
152
Crown Holdings
CCK
$12.8B
| $60.5M | 0.15% |
+929,052
| New | +$58.5M |
|
153
Autodesk
ADSK
$49.5B
| $60.4M | 0.15% |
252,689
+2,500
| +1% | +$491K |
|
154
Dominion Energy
D
$60.8B
| $60.4M | 0.15% |
743,866
-199,514
| -21% | -$16M |
|
155
Toyota
TM
$224B
| $60.2M | 0.15% |
479,208
+75,000
| +19% | +$9.3M |
|
156
Humana
HUM
$43.7B
| $59M | 0.15% |
152,110
+700
| +0.5% | +$262K |
|
157
East-West Bancorp
EWBC
$17.9B
| $58.5M | 0.15% |
1,613,389
-223,636
| -12% | -$7.47M |
|
158
Intercontinental Exchange
ICE
$85.6B
| $58.3M | 0.15% |
636,190
+36,300
| +6% | +$3.32M |
|
159
Boston Scientific
BSX
$69.5B
| $58M | 0.15% |
1,652,416
+255,200
| +18% | +$9.19M |
|
160
Immunovant
IMVT
$7.93B
| $57.6M | 0.15% |
2,366,062
+1,346,062
| +132% | +$28.8M |
|
161
Newmont
NEM
$98.7B
| $57.5M | 0.15% |
931,900
-13,400
| -1% | -$793K |
|
162
Knight Transportation
KNX
$11.3B
| $57.4M | 0.15% |
1,376,891
-135,000
| -9% | -$5.15M |
|
|
SUM
163
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
| $57.3M | 0.15% |
3,623,148
-684,550
| -16% | -$9.82M |
|
164
Martin Marietta Materials
MLM
$31.5B
| $56.8M | 0.15% |
274,957
-72,614
| -21% | -$14M |
|
165
ConocoPhillips
COP
$147B
| $56.7M | 0.15% |
1,350,392
-1,101,100
| -45% | -$44.5M |
|
166
Air Products & Chemicals
APD
$65.7B
| $56.6M | 0.15% |
234,458
+15,500
| +7% | +$3.54M |
|
167
XP
XP
$8.81B
| $56.3M | 0.14% |
1,341,046
-1,728,596
| -56% | -$53M |
|
168
Travelers Companies
TRV
$78.1B
| $55.4M | 0.14% |
+486,094
| New | +$51.2M |
|
|
CXO
169
DELISTED
CONCHO RESOURCES INC.
CXO
| $55.3M | 0.14% |
1,074,400
+256,400
| +31% | +$14.2M |
|
170
Jabil
JBL
$33B
| $54.9M | 0.14% |
1,709,798
+68,251
| +4% | +$1.96M |
|
171
Assurant
AIZ
$13.8B
| $53.6M | 0.14% |
518,740
-51,000
| -9% | -$5.28M |
|
172
Dollar General
DG
$28B
| $53.6M | 0.14% |
281,123
-397,182
| -59% | -$71.9M |
|
173
CSX Corp
CSX
$93.4B
| $53.3M | 0.14% |
2,292,504
-247,200
| -10% | -$5.47M |
|
|
GRMN
174
Garmin
GRMN
$56.7B
| $53.2M | 0.14% |
546,119
+407,040
| +293% | +$34.8M |
|
|
MRSH
175
Marsh
MRSH
$90.5B
| $53.2M | 0.14% |
495,379
+9,700
| +2% | +$982K |
|
Similar funds
Adage Capital Partners's Q2 2020 Portfolio in Review
As of Q2 2020, Adage Capital Partners held 834 positions worth $39.1B, up 17% from $33.5B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Adage Capital Partners withdrew a net $1.33B in Q2 2020, closing 110 positions and reducing 309 holdings. Its most notable exit was Allergan plc, an estimated $1.66B position sold in full.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Adage Capital Partners opened a new position in Royalty Pharma worth $2.23B.
- Adage Capital Partners's largest Q2 2020 buy was Royalty Pharma: 46,015,330 shares worth $2.23B.
- Adage Capital Partners added most to Burlington in Q2 2020, an estimated $191M increase.
- Adage Capital Partners's biggest Q2 2020 reduction was Lockheed Martin, cutting an estimated $339M.
- Adage Capital Partners fully exited Allergan plc in Q2 2020, selling an estimated $1.66B.
- Adage Capital Partners's ten largest holdings make up 25% of its $39.1B portfolio in Q2 2020.
- Adage Capital Partners opened 111 new positions and closed 110 in Q2 2020.
- Adage Capital Partners's portfolio value rose 17% quarter-over-quarter to $39.1B.
Based on Adage Capital Partners's 13F filing for Q2 2020, filed 14 Aug 2020.